Rodent lesion models show conflicting results about whether agonism on CB1 is neuroprotective, exacerbatory, or useful in the treatment of HD symptoms because it is not clear if the loss of these receptors could preclude their therapeutic use (31). This evidence concerns the gene CNR1 and Huntington disease.